Cochrane Database of Systematic Reviews

Risperidone versus other atypical antipsychotic medication

for schizophrenia (Review)

Gilbody S, Bagnall AM, Duggan L, Tuunainen A

Gilbody S, Bagnall AM, Duggan L, Tuunainen A.

Risperidone versus other atypical antipsychotic medication for schizophrenia.
Cochrane Database of Systematic Reviews 2016, Issue 9. Art. No.: CD002306.
DOI: 10.1002/14651858.CD002306.pub2.

www.cochranelibrary.com

Risperidone versus other atypical antipsychotic medication for schizophrenia (Review)

Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
 TABLE OF CONTENTS
HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
REASON FOR WITHDRAWAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
WHAT’S NEW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

Risperidone versus other atypical antipsychotic medication for schizophrenia (Review) i

Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]

Risperidone versus other atypical antipsychotic medication

for schizophrenia

Simon Gilbody1 , Anne-Marie Bagnall2 , Lorna Duggan3 , Arja Tuunainen4

1 Department of Health Sciences, University of York, York, UK. 2 Faculty of Health, Leeds Metropolitan University, Leeds, UK.
3 Kneeswork House Hosptial, Herts, UK. 4 Department of Psychiatry, University of Helsinki, Hus, Finland

Contact address: Simon Gilbody, Department of Health Sciences, University of York, Seebohm Rowntree Building, York, YO10 5DD,
UK. sg519@york.ac.uk.

Editorial group: Cochrane Schizophrenia Group.

Publication status and date: Withdrawn from publication for reasons stated in the review, published in Issue 9, 2016.
Review content assessed as up-to-date: 24 May 2000.

Citation: Gilbody S, Bagnall AM, Duggan L, Tuunainen A. Risperidone versus other atypical antipsychotic medication for schizophre-
nia. Cochrane Database of Systematic Reviews 2016, Issue 9. Art. No.: CD002306. DOI: 10.1002/14651858.CD002306.pub2.

Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

The editorial group responsible for this previously published document have withdrawn it from publication.

REASON FOR WITHDRAWAL

Cochrane Schizophrenia Group internal peer review complete (see Module).
External peer review scheduled.
This review has been updated and replaced by
Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S. Risperidone versus other atypical an-
tipsychotics for schizophrenia. Cochrane Database of Systematic Reviews 2007 , Issue 3 . Art. No.: CD006626. DOI: 10.1002/
14651858.CD006626 .

WHAT’S NEW
Last assessed as up-to-date: 24 May 2000.

Date Event Description

13 January 2011 Amended Has been replaced by newer review of same title by K.Komossa

Risperidone versus other atypical antipsychotic medication for schizophrenia (Review) 1

Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
HISTORY
Review first published: Issue 3, 2000

Date Event Description

15 February 2010 Amended Contact details updated.

31 October 2008 Amended Converted to new review format.

SOURCES OF SUPPORT

Internal sources
• NHS Centre for Reviews and Dissemination, UK.
• Medical Research Council Fellowship Programme, UK.
• NHS Health Technology Assessment Programme, UK.
• St Andrew’s Hospital, UK.
• Helsinki University Central Hospital (HUCH), Finland.

External sources
• Finska Läkaresällskapet (Finnish Medical Society), Finland.
• National Research and Development Centre for Welfare and Health (STAKES), Finland.

Risperidone versus other atypical antipsychotic medication for schizophrenia (Review) 2

Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.